The progressive improvement of lymphoma therapies has led to a significant prolongation of
patient survival and life expectancy. However, lymphoma survivors are at high risk of …

Several outpatient models for the follow-up of cancer survivors have been developed
worldwide. A multidisciplinary approach is often necessary to guarantee the best monitoring …

Post-treatment follow-up is an important phase in the management of lymphoma patients, as
it is required to confirm the status of complete response (CR) achieved after any therapy with …

Simple Summary Lymphoproliferative disorders are commonly observed in the elderly
population and usually their treatment can cause numerous side effects, loss of autonomy …

Recent advances in treatment of patients with aggressive lymphomas ranging from chimeric
antigen receptor T-cell therapy to combination of antibody–drug conjugates with …

Rational therapeutic choice for older patients with lymphoma : Current Opinion in Oncology
Rational therapeutic choice for older patients with lymphoma : Current Opinion in Oncology Log …

PURPOSE Lymphomas are a heterogeneous group of diseases that develop in individuals
of all ages and have variable prognoses. Improved survival resulting from therapy advances …

Purpose Lymphoma survivors who have received curative intent treatment are currently
followed up at defined time points in medical and nurse-led clinics often indefinitely. The …

Recent advancements in cancer care, coupled with early detection and an aging population
have resulted in significant growth of cancer survivors. Long term follow up of such survivors …

As a result of therapeutic advances, there is a growing population of survivors of both
Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL). A thorough understanding …